NCT00236977View on ClinicalTrials.gov

Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia

PHASE3CompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Anemia
Interventions
DRUG

Venofer

iron sucrose injection; 500 mg intravenous (IV) infusion administered over 3.5-4 hours on Days 0 and 14, or 200 mg injections administered over 2-5 minutes on 5 different occasions from Day 0 to Day 14.

DRUG

Ferrous Sulfate

oral iron tablets; 325 mg three times a day orally for 56 days

Trial Locations (1)

19403

Luitpold Pharmaceuticals, Valley Forge

Sponsors
All Listed Sponsors
lead

American Regent, Inc.

INDUSTRY